Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display

3610 - Sexual satisfaction, anxiety, depression and quality of life amoung Turkish gynecological cancer patients


08 Oct 2016


Poster Display


Yasar Yildiz


Annals of Oncology (2016) 27 (6): 296-312. 10.1093/annonc/mdw374


Y. Yildiz1, M. Akyol2, A. Alacacioglu2, Y. Kucukzeybek2, N. Asık2, H. Taskaynatan3, U. Varol3, I. Yildiz4, U. Oflazoglu5, T. Salman3, S.U. Ozaltas2, M.O. Tarhan6

Author affiliations

  • 1 Katip Celebi University, Ataturk Training and Research Hospital,Izmir Katip Celebi University, 35360 - Izmir/TR
  • 2 Medical Oncology, Ataturk Training and Research Hospital,Izmir Katip Celebi University, 35360 - Izmir/TR
  • 3 Medical Oncology, Ataturk Training and Research Hospital,Izmir Katip Celebi University, 35965 - Izmir/TR
  • 4 Oncology, Ataturk Training and Research Hospital,Izmir Katip Celebi University, Izmir/TR
  • 5 Medical Oncology, Ataturk Egitim ve Arastirma Hastanesi tibbi onkoloji klinik, Izmir/TR
  • 6 Medical Oncology, Dokuz Eylul University School of Medicine, Institute of Oncology, 35020 - Izmir/TR


Abstract 3610


Treatments of gynecologic cancer can impact a patient's self-esteem and body image and can create significant physical barriers, such as pain, to satisfactory sexual experiences, as treatments affect the organs associated with sexuality and in the period of life in which sexuality is of great importance. Gynecological cancer patients (GCPs) suffer from several physical and psychological problems. We aimed to investigate anxiety, depression, quality of life and sexual satisfaction levels of gynecological cancer patients (GCPs).


In this study, 62 patients with gynecologic cancer were included. The forms consist of Golombok- Rust Inventory of Ssexual Satisfaction (GRISS), State-Trait Anxiety (STAI) and European Organization for Research on Treatment of Cancer Questionnaires Quality of Life-C30 were used.


The EORTC-QLQ-C30 scores of the patients were compared with their anxiety, depression and hopelessness. There was a statistical significance in the physical functioning (p = 0.020), role functioning(p = 0.006) and emotional functioning (p= 0.0001) when the anxiety scores were high. There was a similar significance in the physical (p = 0.014), cognitive (p = 0.001) and social functions (p= 0.001) when the depression scores were high. When hopelessness scores were high, only physical functioning (p = 0.013) was notable. When we evaluated GRISS subscores and anxiety levels, we found significant increase in satisfaction (p = 0.03) and vaginismus (p = 0.002) in the GCPs. When we evaluated GRISS subscores and depression levels, GRISS subscores of the GCPs who had high depression scores were also high. However, statistical significance was found in satisfaction (p = 0.027), and erectile dysfunction (p = 0.043) subscores in the GCPs. There was a significance in the frequency (p= 0.017), satisfaction (p= 0.019) and avoidance (p = 0.032) in the high hopelessness score.


This study shows that there is a significant association with anxiety, depression symptoms and quality of life scores and sexual dysfunction. Patients' quality of life may be increased by taking precautions to reduce their psychosocial and psychosexual concerns.

Clinical trial identification

Legal entity responsible for the study

Ahmet Alacacıoglu


ızog (Izmir Oncology Group )


All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings